From the ∗Hospices Civils de Lyon

†Centre Max Weber (UMR 5283), Institut des Sciences de l’Homme

‡Université Lumière Lyon 2

§Université Claude Bernard Lyon 1 (INSERM U1290), Lyon, France.

Correspondence: Pauline Occelli, MD, PhD, CHU Grenoble Alpes, Pôle de Santé Publique, CS 90338, 38434 Echirolles Cedex (e-mail: [email protected]).

ORCID ID: 0000-0002-8384-8087.

The authors disclose no conflict of interest.

Supported by a grant from the Programme de Recherche en Qualité Hospitalière 2011 of the French ministry of health (Ministère chargé de la Santé, Direction de l’Hospitalisation et de l’Organisation des Soins). The funder had no role in study design, data collection, data analysis, decision to publish, or writing of the manuscript.

Supported by the French Ministry of Health (Grant Numbers PREPS 14_0389, 2014).

The study was conceptualized and designed by P.O. and P.M. P.O. and K.B.-P. are the co-chief investigators and provided leadership for the project. S.T. and M.R. served as scientific advisors. F.M. planned and carried out the interviews. F.M. and M.R. carried out the analysis. F.M., P.O., and S.T. drafted the manuscript. All authors reviewed the draft version, made suggestions, and approved the final version.

Data are available upon reasonable request.

The study was submitted to the Committee for the Protection of Persons South-East IV in December 2015. The National Commission for Liberties and Data Protection gave approval in September 2016. The study has been registered at ClinicalTrials.gov in July 2016 (NCT02820545).

All methods and procedures were carried out in accordance with the ICH E6 Good Clinical Practice, the Declaration of Helsinki, and the French Law.

According to French law at the time of the study, consent from patients was not required by the committee as no important harm and unintended effects were expected and as no randomization at the patient level was done. The participating patients received information about the study.